4,4'-Dimethylaminorex

From Wikipedia, the free encyclopedia
Jump to: navigation, search
4,4'-DMAR
44dimethylaminorex structure.png
Systematic (IUPAC) name
4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine
Clinical data
Legal status ?
Identifiers
CAS number 1445569-01-6 YesY
ATC code None
PubChem CID 20741615
Chemical data
Formula C11H14N2O 
Mol. mass 190.24 g/mol

4,4'-Dimethylaminorex (4,4'-DMAR) is a centrally acting sympathomimetic drug related to 4-methylaminorex and pemoline. It was first detected in the Netherlands in December 2012,[1] and has been sold as a designer drug around Europe since mid-2013, having been found in Denmark, Hungary, Finland, Sweden and the United Kingdom. 4,4'-DMAR had been linked to at least 26 deaths in Hungary and the UK by February 2014, mostly when consumed in combination with other drugs.[2] Nineteen deaths linked to 4,4'-DMAR were reported in Northern Ireland in the same time period.[3]

See also[edit]

References[edit]